View Past PerformanceCOSMOS Pharmaceutical バランスシートの健全性財務の健全性 基準チェック /46COSMOS Pharmaceuticalの総株主資本は¥274.3B 、総負債は¥50.8Bで、負債比率は18.5%となります。総資産と総負債はそれぞれ¥546.7Bと¥272.5Bです。 COSMOS Pharmaceuticalの EBIT は¥40.3Bで、利息カバレッジ比率112.4です。現金および短期投資は¥30.9Bです。主要情報18.51%負債資本比率JP¥50.76b負債インタレスト・カバレッジ・レシオ112.4x現金JP¥30.88bエクイティJP¥274.26b負債合計JP¥272.49b総資産JP¥546.75b財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 09COSMOS Pharmaceutical Corporation to Report Fiscal Year 2026 Results on Jul 13, 2026COSMOS Pharmaceutical Corporation announced that they will report fiscal year 2026 results on Jul 13, 2026お知らせ • Apr 03COSMOS Pharmaceutical Corporation to Report Q3, 2026 Results on Apr 13, 2026COSMOS Pharmaceutical Corporation announced that they will report Q3, 2026 results on Apr 13, 2026お知らせ • Jan 14Cosmos Pharmaceutical Corporation Announces Dividend for the Second Quarter-End of the Fiscal Year Ending May 31, 2026, Payable on February 12, 2026COSMOS Pharmaceutical Corporation announced dividend of JPY 37.50 per share for the second quarter-end of the fiscal year ending May 31, 2026 against JPY 32.50 per share paid a year ago. Scheduled date of commencing dividend payments is February 12, 2026.お知らせ • Nov 05COSMOS Pharmaceutical Corporation to Report Q2, 2026 Results on Jan 13, 2026COSMOS Pharmaceutical Corporation announced that they will report Q2, 2026 results on Jan 13, 2026お知らせ • Jul 30COSMOS Pharmaceutical Corporation to Report Q1, 2026 Results on Oct 14, 2025COSMOS Pharmaceutical Corporation announced that they will report Q1, 2026 results on Oct 14, 2025お知らせ • Jul 13+ 3 more updatesCOSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Fiscal Year Ended May 31, 2025, Payable on August 4, 2025COSMOS Pharmaceutical Corporation resolved to distribute dividends of surplus with a record date of May 31, 2025. The details of which are as below. Record date: May 31, 2025,Dividend per share JPY 37.50. Total amount of dividends: JPY 2,972 million . Effective date: August 4, 2025 Source of dividends Retained earnings as compared to the dividend of JPY 60.00 (JPY 30.00) per share paid an year ago. The Company conducted a 2-for-1 stock split effective September 1, 2024. Dividends per share for the fiscal year ended May 31, 2024 are based on the number of shares before such stock split. For your reference, the figure shown in parentheses represents the amount per share reflecting the aforementioned stock split.お知らせ • Jul 11COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 21, 2025COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 21, 2025.お知らせ • May 01COSMOS Pharmaceutical Corporation to Report Fiscal Year 2025 Results on Jul 11, 2025COSMOS Pharmaceutical Corporation announced that they will report fiscal year 2025 results on Jul 11, 2025お知らせ • Feb 03COSMOS Pharmaceutical Corporation to Report Q3, 2025 Results on Apr 11, 2025COSMOS Pharmaceutical Corporation announced that they will report Q3, 2025 results on Apr 11, 2025お知らせ • Jan 10Cosmos Pharmaceutical Corporation Announces Dividend for the Second Quarter-End of Fiscal Year Ending May 31, 2025, Payable on February 12, 2025COSMOS Pharmaceutical Corporation announced dividend of JPY 32.50 per share for the second quarter-end of fiscal year ending May 31, 2025 compared to JPY 60.00 per share paid a year ago. Scheduled date of commencing dividend payments: February 12, 2025.お知らせ • Oct 29COSMOS Pharmaceutical Corporation to Report Q2, 2025 Results on Jan 10, 2025COSMOS Pharmaceutical Corporation announced that they will report Q2, 2025 results on Jan 10, 2025お知らせ • Aug 09COSMOS Pharmaceutical Corporation to Report Q1, 2025 Results on Oct 11, 2024COSMOS Pharmaceutical Corporation announced that they will report Q1, 2025 results on Oct 11, 2024お知らせ • Jul 13COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 20, 2024COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 20, 2024.お知らせ • Jul 12+ 1 more updateCOSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Fiscal Year Ended May 31, 2024, Payable on August 1, 2024; Provides Second Quarter End and Year End Dividend Guidance for the Fiscal Year Ending May 31, 2025COSMOS Pharmaceutical Corporation announced year-end dividend of JPY 60.00 per share for the fiscal year ended May 31, 2024 compared to JPY 57.50 per share a year ago. Scheduled date of commencing dividend payments: August 1, 2024.The company expects second quarter end dividend of JPY 32.50 per share for the fiscal year ending May 31, 2025 compared to JPY 60.00 per share a year ago.The company expects year end dividend of JPY 32.50 per share for the fiscal year ending May 31, 2025 compared to JPY 60.00 per share a year ago. Dividends per share for the fiscal year ending May 31, 2025 (forecast) take into account the effect of the said stock split.お知らせ • Jan 31COSMOS Pharmaceutical Corporation to Report Q3, 2024 Results on Apr 12, 2024COSMOS Pharmaceutical Corporation announced that they will report Q3, 2024 results on Apr 12, 2024お知らせ • Jan 12+ 1 more updateCOSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024COSMOS Pharmaceutical Corporation provided consolidated earnings guidance for the fiscal year ending May 31, 2024. For the period, the company expects net sales of JPY 916,000 million, operating profit of JPY 30,200 million, profit attributable to owners of parent of JPY 23,800 million and basic earnings per share of JPY 601.03.お知らせ • Nov 01COSMOS Pharmaceutical Corporation to Report Q2, 2024 Results on Jan 12, 2024COSMOS Pharmaceutical Corporation announced that they will report Q2, 2024 results on Jan 12, 2024お知らせ • Oct 11COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024COSMOS Pharmaceutical Corporation provided consolidated earnings guidance for the first half and full year of fiscal year ending May 31, 2024. For the first half, the company expects net sales of JPY 450,400 million, operating profit of JPY 14,100 million, profit attributable to owners of parent of JPY 10,577 million and basic earnings per share of JPY 267.10.For the full year, the company expects net sales of JPY 916,000 million, operating profit of JPY 30,200 million, profit attributable to owners of parent of JPY 23,800 million and basic earnings per share of JPY 601.03.お知らせ • Aug 03COSMOS Pharmaceutical Corporation to Report Q1, 2024 Results on Oct 11, 2023COSMOS Pharmaceutical Corporation announced that they will report Q1, 2024 results on Oct 11, 2023お知らせ • Jul 12+ 2 more updatesCOSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 22, 2023COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 22, 2023.お知らせ • Feb 09COSMOS Pharmaceutical Corporation to Report Q3, 2023 Results on Apr 10, 2023COSMOS Pharmaceutical Corporation announced that they will report Q3, 2023 results on Apr 10, 2023お知らせ • Jan 14Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023COSMOS Pharmaceutical Corporation provided earnings Forecast for the Fiscal Year Ending May 31, 2023. For the period, The company expects Net sales of JPY 813,500 million. Operating profit of JPY 30,000 million. Profit attributable to owners of parent of JPY 23,200 million. Basic earnings per share of JPY 585.87.お知らせ • Oct 30COSMOS Pharmaceutical Corporation to Report Q2, 2023 Results on Jan 12, 2023COSMOS Pharmaceutical Corporation announced that they will report Q2, 2023 results on Jan 12, 2023財務状況分析短期負債: CSMY.Fの 短期資産 ( ¥151.2B ) は 短期負債 ( ¥229.4B ) をカバーしていません。長期負債: CSMY.Fの短期資産 ( ¥151.2B ) が 長期負債 ( ¥43.1B ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: CSMY.Fの 純負債対資本比率 ( 7.2% ) は 満足できる 水準であると考えられます。負債の削減: CSMY.Fの負債対資本比率は、過去 5 年間で3.6%から18.5%に増加しました。債務返済能力: CSMY.Fの負債は 営業キャッシュフロー によって 十分にカバー されています ( 117.3% )。インタレストカバレッジ: CSMY.Fの負債に対する 利息支払い は EBIT ( 112.4 x coverage) によって 十分にカバーされています。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YConsumer-retailing 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/11 09:46終値2026/05/27 00:00収益2026/02/28年間収益2025/05/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋COSMOS Pharmaceutical Corporation 10 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。18 アナリスト機関Arashi NishizawaBofA Global ResearchMitsuru TakayanagiCitigroup IncCiti ResearchCitigroup Inc15 その他のアナリストを表示
お知らせ • May 09COSMOS Pharmaceutical Corporation to Report Fiscal Year 2026 Results on Jul 13, 2026COSMOS Pharmaceutical Corporation announced that they will report fiscal year 2026 results on Jul 13, 2026
お知らせ • Apr 03COSMOS Pharmaceutical Corporation to Report Q3, 2026 Results on Apr 13, 2026COSMOS Pharmaceutical Corporation announced that they will report Q3, 2026 results on Apr 13, 2026
お知らせ • Jan 14Cosmos Pharmaceutical Corporation Announces Dividend for the Second Quarter-End of the Fiscal Year Ending May 31, 2026, Payable on February 12, 2026COSMOS Pharmaceutical Corporation announced dividend of JPY 37.50 per share for the second quarter-end of the fiscal year ending May 31, 2026 against JPY 32.50 per share paid a year ago. Scheduled date of commencing dividend payments is February 12, 2026.
お知らせ • Nov 05COSMOS Pharmaceutical Corporation to Report Q2, 2026 Results on Jan 13, 2026COSMOS Pharmaceutical Corporation announced that they will report Q2, 2026 results on Jan 13, 2026
お知らせ • Jul 30COSMOS Pharmaceutical Corporation to Report Q1, 2026 Results on Oct 14, 2025COSMOS Pharmaceutical Corporation announced that they will report Q1, 2026 results on Oct 14, 2025
お知らせ • Jul 13+ 3 more updatesCOSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Fiscal Year Ended May 31, 2025, Payable on August 4, 2025COSMOS Pharmaceutical Corporation resolved to distribute dividends of surplus with a record date of May 31, 2025. The details of which are as below. Record date: May 31, 2025,Dividend per share JPY 37.50. Total amount of dividends: JPY 2,972 million . Effective date: August 4, 2025 Source of dividends Retained earnings as compared to the dividend of JPY 60.00 (JPY 30.00) per share paid an year ago. The Company conducted a 2-for-1 stock split effective September 1, 2024. Dividends per share for the fiscal year ended May 31, 2024 are based on the number of shares before such stock split. For your reference, the figure shown in parentheses represents the amount per share reflecting the aforementioned stock split.
お知らせ • Jul 11COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 21, 2025COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 21, 2025.
お知らせ • May 01COSMOS Pharmaceutical Corporation to Report Fiscal Year 2025 Results on Jul 11, 2025COSMOS Pharmaceutical Corporation announced that they will report fiscal year 2025 results on Jul 11, 2025
お知らせ • Feb 03COSMOS Pharmaceutical Corporation to Report Q3, 2025 Results on Apr 11, 2025COSMOS Pharmaceutical Corporation announced that they will report Q3, 2025 results on Apr 11, 2025
お知らせ • Jan 10Cosmos Pharmaceutical Corporation Announces Dividend for the Second Quarter-End of Fiscal Year Ending May 31, 2025, Payable on February 12, 2025COSMOS Pharmaceutical Corporation announced dividend of JPY 32.50 per share for the second quarter-end of fiscal year ending May 31, 2025 compared to JPY 60.00 per share paid a year ago. Scheduled date of commencing dividend payments: February 12, 2025.
お知らせ • Oct 29COSMOS Pharmaceutical Corporation to Report Q2, 2025 Results on Jan 10, 2025COSMOS Pharmaceutical Corporation announced that they will report Q2, 2025 results on Jan 10, 2025
お知らせ • Aug 09COSMOS Pharmaceutical Corporation to Report Q1, 2025 Results on Oct 11, 2024COSMOS Pharmaceutical Corporation announced that they will report Q1, 2025 results on Oct 11, 2024
お知らせ • Jul 13COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 20, 2024COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 20, 2024.
お知らせ • Jul 12+ 1 more updateCOSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Fiscal Year Ended May 31, 2024, Payable on August 1, 2024; Provides Second Quarter End and Year End Dividend Guidance for the Fiscal Year Ending May 31, 2025COSMOS Pharmaceutical Corporation announced year-end dividend of JPY 60.00 per share for the fiscal year ended May 31, 2024 compared to JPY 57.50 per share a year ago. Scheduled date of commencing dividend payments: August 1, 2024.The company expects second quarter end dividend of JPY 32.50 per share for the fiscal year ending May 31, 2025 compared to JPY 60.00 per share a year ago.The company expects year end dividend of JPY 32.50 per share for the fiscal year ending May 31, 2025 compared to JPY 60.00 per share a year ago. Dividends per share for the fiscal year ending May 31, 2025 (forecast) take into account the effect of the said stock split.
お知らせ • Jan 31COSMOS Pharmaceutical Corporation to Report Q3, 2024 Results on Apr 12, 2024COSMOS Pharmaceutical Corporation announced that they will report Q3, 2024 results on Apr 12, 2024
お知らせ • Jan 12+ 1 more updateCOSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024COSMOS Pharmaceutical Corporation provided consolidated earnings guidance for the fiscal year ending May 31, 2024. For the period, the company expects net sales of JPY 916,000 million, operating profit of JPY 30,200 million, profit attributable to owners of parent of JPY 23,800 million and basic earnings per share of JPY 601.03.
お知らせ • Nov 01COSMOS Pharmaceutical Corporation to Report Q2, 2024 Results on Jan 12, 2024COSMOS Pharmaceutical Corporation announced that they will report Q2, 2024 results on Jan 12, 2024
お知らせ • Oct 11COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024COSMOS Pharmaceutical Corporation provided consolidated earnings guidance for the first half and full year of fiscal year ending May 31, 2024. For the first half, the company expects net sales of JPY 450,400 million, operating profit of JPY 14,100 million, profit attributable to owners of parent of JPY 10,577 million and basic earnings per share of JPY 267.10.For the full year, the company expects net sales of JPY 916,000 million, operating profit of JPY 30,200 million, profit attributable to owners of parent of JPY 23,800 million and basic earnings per share of JPY 601.03.
お知らせ • Aug 03COSMOS Pharmaceutical Corporation to Report Q1, 2024 Results on Oct 11, 2023COSMOS Pharmaceutical Corporation announced that they will report Q1, 2024 results on Oct 11, 2023
お知らせ • Jul 12+ 2 more updatesCOSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 22, 2023COSMOS Pharmaceutical Corporation, Annual General Meeting, Aug 22, 2023.
お知らせ • Feb 09COSMOS Pharmaceutical Corporation to Report Q3, 2023 Results on Apr 10, 2023COSMOS Pharmaceutical Corporation announced that they will report Q3, 2023 results on Apr 10, 2023
お知らせ • Jan 14Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023COSMOS Pharmaceutical Corporation provided earnings Forecast for the Fiscal Year Ending May 31, 2023. For the period, The company expects Net sales of JPY 813,500 million. Operating profit of JPY 30,000 million. Profit attributable to owners of parent of JPY 23,200 million. Basic earnings per share of JPY 585.87.
お知らせ • Oct 30COSMOS Pharmaceutical Corporation to Report Q2, 2023 Results on Jan 12, 2023COSMOS Pharmaceutical Corporation announced that they will report Q2, 2023 results on Jan 12, 2023